Outcomes of nodal metastatic cutaneous squamous cell carcinoma of the head and neck treated in a regional center

Head and Neck

Volumn 37, Issue 12, 2015, Pages 1808-1815

  Schmidt, Campbell ^a   Martin, Jarad M ^b   Khoo, Eric ^c   Plank, Ashley ^d   Grigg, Roger ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^c Radiation Oncology Queensland   (Australia)

^d Oncology Research Australia   (Australia)

Author keywords

carcinoma; head and neck neoplasms; lymphatic metastasis; rural health services; squamous cell; survival analysis

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER CLASSIFICATION; CHEMORADIOTHERAPY; CUTANEOUS SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; SKIN CARCINOMA; AUSTRALIA; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; FOLLOW UP; HEAD AND NECK NEOPLASMS; IMMUNOCOMPROMISED PATIENT; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NECK DISSECTION; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SECONDARY; SKIN NEOPLASMS; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84954402871     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23843     Document Type: Article

References (40)

1. Ramirez CC, Federman DG, Kirsner RS,. Skin cancer as an occupational disease: the effect of ultraviolet and other forms of radiation. Int J Dermatol 2005; 44: 95-100.
2. Australian Institute of Health and Welfare, Cancer Australia. Non-melanoma skin cancer: general practice consultations, hospitalisation and mortality. Cancer series: no. 43. Cat. no. 39. Canberra: Australian Institute of Health and Welfare; 2008.
3. Buettner PG, Raasch BA,. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998; 78: 587-593.
4. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG,. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006; 184: 6-10.
5. Clayman GL, Lee JJ, Holsinger FC, et al., Mortality risk from squamous cell skin cancer. J Clin Oncol 2005; 23: 759-765.
6. Jambusaria-Pahlajani A, Miller CJ, Quon H, Smith N, Klein RQ, Schmults CD,. Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg 2009; 35: 574-585.
7. Veness MJ, Porceddu S, Palme CE, Morgan GJ,. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007; 29: 621-631.
8. Givi B, Andersen PE, Diggs BS, Wax MK, Gross ND,. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Head Neck 2011; 33: 999-1004.
9. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. Cutaneous squamous cell carcinoma and other cutaneous carcinomas. AJCC Cancer Staging Manual. New York, NY: Springer; 2010.
10. Warner CL, Cockerell CJ,. The new seventh edition American Joint Committee on Cancer staging of cutaneous non-melanoma skin cancer: a critical review. Am J Clin Dermatol 2011; 12: 147-154.
11. Jong KE, Smith DP, Yu XQ, O'Connell DL, Goldstein D, Armstrong BK,. Remoteness of residence and survival from cancer in New South Wales. Med J Aust 2004; 180: 618-622.
12. Giles GG, Marks R, Foley P,. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988; 296: 13-17.
13. SPSS Statistics for Windows, version 21.0. Armonk, NY: IBM Corp; 2012.
14. R Development Core Team. R: a language and environment for statistical computing, version 3.0.2. Vienna, Austria: R Foundation for Statistical Computing; 2013.
15. Therneau T,. A package for survival analysis in S, R package, version 2. 37-2, 2013.
16. Trans-Tasman Radiation Oncology Group (TROG). Postoperative concurrent chemo-radiotherapy versus postoperative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck. ClinicalTrials.gov, [updated 5 August 2013]. Available at: http://clinicaltrials.gov/show/NCT00193895. Accessed August 5, 2013.
17. Ebrahimi A, Clark JR, Ahmadi N, Palme CE, Morgan GJ, Veness MJ,. Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases. Head Neck 2013; 35: 1138-1143.
18. Forest VI, Clark JJ, Veness MJ, Milross C,. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer 2010; 116: 1298-1304.
19. Ch'ng S, Maitra A, Allison RS, et al., Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma. J Surg Oncol 2008; 98: 101-105.
20. Hinerman RW, Indelicato DJ, Amdur RJ, et al., Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes. Laryngoscope 2008; 118: 1989-1996.
21. Andruchow JL, Veness MJ, Morgan GJ, et al., Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer 2006; 106: 1078-1083.
22. Kirke DN, Porceddu S, Wallwork BD, Panizza B, Coman WB,. Pathologic occult neck disease in patients with metastatic cutaneous squamous cell carcinoma to the parotid. Otolaryngol Head Neck Surg 2011; 144: 549-551.
23. Audet N, Palme CE, Gullane PJ, et al., Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome. Head Neck 2004; 26: 727-732.
24. O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS,. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck 2001; 23: 744-748.
25. Dona E, Veness MJ, Cakir B, Morgan GJ,. Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome. ANZ J Surg 2003; 73: 692-696.
26. Moore BA, Weber RS, Prieto V, et al., Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 2005; 115: 1561-1567.
27. Ying YL, Johnson JT, Myers EN,. Squamous cell carcinoma of the parotid gland. Head Neck 2006; 28: 626-632.
28. Veness MJ, Palme CE, Smith M, Cakir B, Morgan GJ, Kalnins I,. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope 2003; 113: 1827-1833.
29. Wang JT, Palme CE, Morgan GJ, Gebski V, Wang AY, Veness MJ,. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy. Head Neck 2012; 34: 1524-1528.
30. Southwell KE, Chaplin JM, Eisenberg RL, McIvor NP, Morton RP,. Effect of immunocompromise on metastatic cutaneous squamous cell carcinoma in the parotid and neck. Head Neck 2006; 28: 244-248.
31. Martinez JC, Otley CC, Stasko T, et al., Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003; 139: 301-306.
32. Mihalov ML, Gattuso P, Abraham K, Holmes EW, Reddy V,. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 1996; 10: 248-255.
33. Veness MJ, Quinn DI, Ong CS, et al., Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999; 85: 1758-1764.
34. Mehrany K, Weenig RH, Lee KK, Pittelkow MR, Otley CC,. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J Am Acad Dermatol 2005; 53: 1067-1071.
35. Oddone N, Morgan GJ, Palme CE, et al., Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer 2009; 115: 1883-1891.
36. Buethe D, Warner C, Miedler J, Cockerell CJ,. Focus issue on squamous cell carcinoma: practical concerns regarding the 7th edition AJCC Staging Guidelines. J Skin Cancer 2011; 2011: 156391.
37. O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA,. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002; 24: 417-422.
38. Palme CE, O'Brien CJ, Veness MJ, McNeil EB, Bron LP, Morgan GJ,. Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2003; 129: 750-753.
39. Brunner M, Veness MJ, Ch'ng S, Elliott M, Clark JR,. Distant metastases from cutaneous squamous cell carcinoma-analysis of AJCC stage IV. Head Neck 2013; 35: 72-75.
40. Veness MJ, Morgan GJ, Palme CE, Gebski V,. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope 2005; 115: 870-875.